Survey on the Clinical Use of Recombinant Human Erythropoietin in VLBW and ELBW Infants

• Conditions: Erythropoietin; Infant; Surveys and Questionnaires
• Interventions: Other: not use of any intervention

• Registration Number: NCT05372211
• Lead Sponsor: Shenzhen People's Hospital

Brief Summary

Recombinant human erythropoietin (rhEPO) has been shown to effectively and safely prevent the anemia of prematurity and to reduce the transfusion need in very low birth weight (VLBW) and extremly low birth weight (ELBW) infants and has been licensed for this indication in Europe in 1997. The objective of the study was to obtain information on the use or nonuse of rhEPO in neonatal units in China.

Detailed Description

The survey was developed by a team of neonatologists at Shenzhen People's hospital . The survey consisted of 26 questions covering three areas: the characteristics of the survey respondents, the use of rhEPO in VLBW and ELBW infants , and other related questions. The questionnaire was presented in the Questionnaire Star format (https://www.wjx.cn/, Hangzhou Oway Medical Technology,Changsha, China). we plan to conduct a cross-sectional survey through the Neonatal Professional Committee of the Chinese Medical Doctor Association WeChat platform. The questionnaire is going to be distributed to nearly 500 representative neonatologists and pediatricians from general hospitals, maternity and infant hospitals, and children's hospitals across the country. Furthermore, this study was approved by the ethics committee of the Shenzhen People's Hospital.

Study Timeline

• Status Verified: 2022-05
• Study First Submitted: 2022-05-09
• Study First Submitted QC: 2022-05-11
• Last Update Submitted: 2022-05-11
• Study First Posted: 2022-05-12
• Last Update Posted: 2022-05-12
• Study Start: 2022-06-01
• Primary Completion: 2022-09-01
• Study Completion: 2022-10-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

neonatologists and pediatricians from general hospitals, maternity and infant hospitals, and children's hospitals across China

Exclusion Criteria

neonatologists and pediatricians from same hospitals

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Maternity and infant hospital group	not use of any intervention	Questionnaires collected from Maternity and infant hospitals in China
General hospital group	not use of any intervention	Questionnaires collected from general hospitals in China
Children's hospital	not use of any intervention	Questionnaires collected from Children's hospitals in China

Primary Outcome Measures

Name	Time	Method
The survey (the clinical use of rhEPO)	01-june-2022	the clinical use of rhEPO in VLBW and ELBW infants